Middle East and Africa Breast Lesion Localization Methods Market

Market Overview

The Middle East and Africa breast lesion localization methods market size has witnessed significant growth in the past and is expected to grow at a CAGR of 14.8% during the forecast period (2022–2031).

The acceptance and usage of breast lesion localization methods, including MRI, ultrasound, and mammography, is contingent upon the healthcare infrastructure of the specific healthcare systems.

Market Dynamics

Middle East and Africa Breast Lesion Localization Methods Market Drivers

Surging Occurrence of Breast Cancer

The evolving market landscape and the emergence of IT companies have caused a shift in people's focus, resulting in a decline in their attention to physical health. This is evident in the sedentary lifestyles that have become prevalent, particularly among working women who prioritize convenience over nutritious cooking and instead choose high-calorie processed foods and fast-food options. These dietary changes have played a significant role in the growing problem of obesity, a major factor contributing to the increasing incidence of breast cancer. Additionally, heightened alcohol consumption has exacerbated the prevalence of this disease.

Middle East and Africa Breast Lesion Localization Methods Market Restraint

Limited Availability of Trained Oncologists

Adequate availability of skilled oncologists is crucial for successfully diagnosing, treating, and caring for cancer patients. However, there is a significant shortage of proficient oncologists delivering comprehensive, high-quality care. Moreover, access to advanced localization technology is predominantly limited to developed countries, mainly due to inadequate healthcare infrastructure in other regions. Furthermore, many hospitals that provide oncology services lack the necessary equipment and technologies for precise diagnosis and treatment of breast cancer.

Middle East and Africa Breast Lesion Localization Methods and Market Opportunities

Favorable Growth Environment in Emerging Economies

The rapid urbanization in these countries has led to a significant influx of people into urban areas, necessitating government and private entities' expansion of healthcare infrastructure. Our research reveals that government hospitals in these regions lack technology and resources, prompting private hospitals to invest heavily in advanced equipment to attract more patients and capitalize on the gap in public healthcare services. Additionally, the governments are offering incentives, such as affordable or free land, patient-based incentives, subsidies for treatment costs, and easy access to loans for machinery procurement, to encourage the establishment of new hospitals. Consequently, numerous private players are constructing new hospitals and expanding their networks to establish their brands and strengthen their market position.

Regional Analysis

The Middle East and Africa present a significant market for breast lesion localization methods. The rising incidence of breast cancer and increasing awareness about early detection and diagnosis drive market growth. However, limited healthcare infrastructure and access to advanced technologies pose challenges. Collaborations and partnerships with international companies are being explored to enhance regional healthcare services.

Several countries in the Middle East have robust industries, including Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, and Bahrain. In these nations, the healthcare system is highly developed. Additionally, most patients who reside here have a high per capita income. For this reason, they prefer the most effective treatment and the most advanced cancer detection technology. According to our findings, money is not a significant constraint in the Gulf States. On the other hand, African nations struggle to provide their citizens with essential healthcare.

Segmental Analysis

The market of the Middle East and Africa breast lesion localization methods is segmented into type and usage.

By Type it is further segmented into wire localization, radioisotope localization, magnetic localization, and others.

Wire localization dominated the market and is expected to register a CAGR of 15.2% over the forecast period. Wire localization is used to designate the precise location of the lesion, which assists the surgeon in detecting and removing breast lesions if an X-ray reveals multiple lesions. The technique is favored for removing lesions or tumors that are difficult to locate and cannot be felt. In addition, it can be used to remove the smallest possible area, which would be difficult for a surgeon to do without causing obvious harm to the surrounding tissue. The procedure is painless, but some women may experience pressure or vertigo.

It is further segmented based on usage into tumor identification and sentinel lymph node identification.

Tumor identification dominated the market and is expected to register a CAGR of 14.4% over the forecast period. A physical examination, or breast imaging, which primarily consists of mammography and a biopsy, is performed to identify tumors. It is commonly performed on women with breast cancer. Mammography utilizes X-rays to image the breast region containing a tumor. In addition, various imaging technologies, such as MRI and ultrasound, are also utilized. Ultrasound is primarily recommended for women under the age of 30.

Recent Developments

• January 2021: Hologic, Inc., an innovative medical technology company focused on improving women’s health, announced and completed the acquisition of SOMATEX Medical Technologies GmbH, a leader in biopsy site markers and localization technologies, for approximately USD 64 million. The company was previously owned by E-Med Solutions GmbH, Berlin, a group of investors led by German private equity company Westlake Partners.